Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status | Zendy

Dana Byrne | Zendy; Janet P. Tate | Zendy; Kimberly A. Forde | Zendy; Joseph K. Lim | Zendy; Matthew Bidwell Goetz | Zendy; David Rimland | Zendy; Maria C. RodriguezBarradas | Zendy; Adeel A. Butt | Zendy; Cynthia L. Gibert | Zendy; Sheldon T. Brown | Zendy; Roger Bedimo | Zendy; Matthew S. Freiberg | Zendy; Amy C. Justice | Zendy; Jay R. Kostman | Zendy; Jason Roy | Zendy; Vincent Lo Re | Zendy

Open Access

Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status

Author(s) -

Dana Byrne,

Janet P. Tate,

Kimberly A. Forde,

Joseph K. Lim,

Matthew Bidwell Goetz,

David Rimland,

Maria C. RodriguezBarradas,

Adeel A. Butt,

Cynthia L. Gibert,

Sheldon T. Brown,

Roger Bedimo,

Matthew S. Freiberg,

Amy C. Justice,

Jay R. Kostman,

Jason Roy,

Vincent Lo Re

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix564

Subject(s) - medicine , human immunodeficiency virus (hiv) , statin , hepatitis c virus , virus , virology , immunology , viral disease , liver injury

Patients with human immunodeficiency virus (HIV) and/or chronic hepatitis C virus (HCV) infection may be prescribed statins as treatment for metabolic/cardiovascular disease, but it remains unclear if the risk of acute liver injury (ALI) is increased for statin initiators compared to nonusers in groups classified by HIV/HCV status.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research